Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) in Participants 9 Through 49 Years of Age.

PHASE3CompletedINTERVENTIONAL
Enrollment

1,308

Participants

Timeline

Start Date

October 27, 2022

Primary Completion Date

October 27, 2023

Study Completion Date

October 27, 2023

Conditions
Influenza Immunization
Interventions
BIOLOGICAL

Quadrivalent Recombinant influenza vaccine (RIV4) season/2022-2023/NH

Pharmaceutical form: Solution for injection Route of administration: intramuscular

Trial Locations (35)

13850

Velocity Clinical Research Vestal Site Number : 8400016, Vestal

13905

Meridian Clinical Research Site Number : 8400006, Binghamton

23703

Velocity Clinical Research Portsmouth Site Number : 8400015, Portsmouth

28660

Investigational Site Number : 7240018, Madrid

28938

Investigational Site Number : 7240001, Móstoles

29015

Investigational Site Number : 7240005, Málaga

29405

Coastal Carolina Research Center - N Charleston Site Number : 8400022, North Charleston

29414

Coastal Pediatric Research Charleston Site Number : 8400005, Charleston

29812

Rainbow Pediatrics Site Number : 8400014, Barnwell

35205

Alabama Clinical Therapeutics North Tower Site Number : 8400024, Birmingham

Birmingham Pediatric Associates Site Number : 8400023, Birmingham

37701

Investigational Site Number : 2030001, Jindřichův Hradec

40004

Kentucky Pediatics / Adult Research Site Number : 8400010, Bardstown

41014

Investigational Site Number : 7240007, Seville

45414

Ohio Pediatric Research Site Number : 8400020, Dayton

51106

Meridian Clinical Research- Sioux City Site Number : 8400007, Sioux City

67114

AMR - Newton Site Number : 8400021, Newton

68134

Velocity Clinical Research, Omaha Site Number : 8400009, Omaha

68510

Velocity Clinical Research Lincoln Site Number : 8400013, Lincoln

68701

Meridian Clinical Research Norfolk Site Number : 8400011, Norfolk

70119

Velocity Clinical Research Site Number : 8400012, New Orleans

72401

The Children's Clinic Of Jonesboro PA Site Number : 8400025, Jonesboro

78705

Benchmark Research - Austin Site Number : 8400004, Austin

84107

JBR Clinical Research Site Number : 8400001, Salt Lake City

84109

J. Lewis Research Site Number : 8400017, Salt Lake City

92123-1881

California Research Foundation Site Number : 8400003, San Diego

85-048

Investigational Site Number : 6160010, Bydgoszcz

85-079

Investigational Site Number : 6160007, Bydgoszcz

24-100

Investigational Site Number : 6160004, PuÅ'awy

41-103

Investigational Site Number : 6160005, Siemianowice Śląskie

85-796

Investigational Site Number : 6160003, Bydgoszcz

33-100

Investigational Site Number : 6160006, Tarnów

02-637

Investigational Site Number : 6160008, Warsaw

53-149

Investigational Site Number : 6160012, Wroclaw

08540

Investigational Site Number : 7240006, Centelles

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY